Latest News about FDA
Recent news which mentions FDA
OKYO Pharma Files US IND Application For Dry Eye Disease Candidate
November 21, 2022
Tickers
OKYO
From Benzinga
Psychedelics Move Forward In Congress: Sens. Booker And Paul File 'Breakthrough Therapies Act'
November 18, 2022
From Benzinga
Apellis Pharma Shares Jump As FDA Accepts Its Lead Product Application For Eye Disease
November 18, 2022
Tickers
APLS
From Benzinga
Iovance Biotherapeutics Pushes FDA Rolling Submission Deadline Into Next Year For Its Lead Skin Cancer Candidate
November 18, 2022
Tickers
IOVA
From Benzinga
From Benzinga
IVERIC bio Secures Breakthrough Therapy Tag For Its Flagship Geographic Atrophy Candidate
November 18, 2022
Tickers
ISEE
From Benzinga
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles
November 18, 2022
From Benzinga
MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
November 17, 2022
From Benzinga
FDA Approves Opioid Overdose Antidote Narcan For OTC Sale
November 17, 2022
Tickers
CDC
From Benzinga
Incannex Initiates BA/BE Clinical Trial Evaluating IHL-42X In Obstructive Sleep Apnoea
November 17, 2022
Tickers
IXHL
From Benzinga
Despite Concerns, FDA Advisory Committee Votes In Favor Of Ardelyx's Kidney Disease Candidate
November 17, 2022
Tickers
ARDX
From Benzinga
FDA Outlines Strategy To Review Infant Formula Production Rules
November 16, 2022
Tickers
ABT
From Benzinga
From Benzinga
FDA Gives Emergency Use Nod To Roche's Monkeypox Test
November 16, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.